The FDA on Friday said it approved Novo Nordisk’s popular weight-loss drug Wegovy to reduce the risk of severe heart issues in overweight or obese adults.
Wegovy gets FDA approval to reduce risk of heart issues in overweight adults
Read Next
- Bitcoin (BTC) Surges to New Heights Amidst Robust Capital Inflows
- LIC losses nearly Rs 9000 crore; PSBs witness fall, ET BFSI
- People who become easier to manipulate as they get older typically display these 8 behaviors (without realizing it)
- CFPB expands oversight of Apple Pay, other digital payments services
- LiquidityBook completes SOC 1 Type 1 and SOC 2 Type 1 audits
- Harnessing AI for Neuroscience: IIT Madras and NVIDIA’s Innovative Approach
- International Criminal Court issues arrest warrants for Netanyahu and Hamas officials
